FIELD: pharmaceutics.
SUBSTANCE: invention relates to use of a combination of a CNP agonist and human growth hormone in treating or preventing achondroplasia and to methods of treating or preventing a patient suffering such a disorder. Said combination of CNP agonist and growth hormone exhibits synergetic effect consisting in increase of average longitudinal growth of long bones, in particular of femur, and width of endochondral zone / zone of ossification. According to the invention, the CNP agonist is a compound of formula (IIf) or a pharmaceutically applicable salt thereof, where the unmarked dotted line denotes the attachment to the nitrogen atom provided by the lysine side chain at position 26 of the CNP component having the sequence SEQ ID NO: 24 by forming an amide bond; and the dotted line marked with an asterisk denotes attachment to -Z, having the structure indicated in the claims.
(IIf).
EFFECT: treating and preventing achondroplasia using a combination of a CNP agonist and human growth hormone.
23 cl, 2 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF OPTIONS OF NATRIURETIC PEPTIDE OF TYPE C FOR TREATMENT OF OSTEOARTHRITIS | 2016 |
|
RU2759679C2 |
PTH COMPOUNDS WITH LOW PEAK-TO-MINIMUM RATIOS | 2017 |
|
RU2766959C2 |
DOSAGE MODE OF PTH COMPOUND OF CONTROLLED RELEASE | 2017 |
|
RU2777357C2 |
METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCORTIN 4 RECEPTOR PATH | 2016 |
|
RU2785889C1 |
ANTIBODY-DRUG CONJUGATES INCLUDING ANTIBODY AGAINST HUMAN DLK1 AND THEIR USE | 2020 |
|
RU2801630C2 |
3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USE THEREOF IN TREATING DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 OF IKAROS (IKZF2) FAMILY | 2019 |
|
RU2815714C2 |
NEW COMPOUNDS | 2019 |
|
RU2812934C2 |
LIQUID PHARMACEUTICAL FORMULATIONS OF PTH CONJUGATES | 2020 |
|
RU2817015C2 |
SULFOMALEIMIDE-BASED LINKERS AND CORRESPONDING CONJUGATES | 2019 |
|
RU2815199C2 |
ANTIBODY-DRUG CONJUGATE, INTERMEDIATE FOR ITS PRODUCTION, METHOD OF ITS PRODUCTION AND ITS USE | 2020 |
|
RU2800137C1 |
Authors
Dates
2022-03-24—Published
2017-09-28—Filed